BioWorld - Thursday, June 4, 2026

BioWorld Science

Nov. 12, 2020

View Archived Issues

Early clinical data reported for [177Lu]rhPSMA-7.3 in mCRPC

Read More

Merck & Co. advances MK-4830 into phase II trial in NSCLC

Read More

AGTC presents positive data from ongoing phase I/II clinical program in XLRP

Read More

Pfizer announces positive data from phase III JADE REGIMEN study of abrocitinib

Read More

Kuling Therapeutics patents RORC antagonists

Read More

Shanghai Institute of Materia Medica discloses NR1H4 agonists

Read More

Massachusetts Institute of Technology synthesizes compounds for cancer

Read More

Alectrona presents new quaternary amine compounds for infections

Read More

RECCE-327 demonstrates encouraging preliminary antiviral activity against SARS-CoV-2

Read More

Y-Biologics discloses IL-17A- and TNFalpha-targeting antibodies

Read More

Metabolic pathway-based TNBC subtyping reveals potential new targets

Read More

EZH2 as novel therapeutic target for chronic kidney disease

Read More

Data presented for NKTR-255 in patients with relapsed/refractory hematologic malignancies

Read More

Experimental aorta transplantation ameliorates uremic vascular calcification in rats

Read More

New immune checkpoint antibody AbGn-168H displays promising efficacy and is well tolerated

Read More

KAHR initiates first-in-human trial of DSP-107 in solid tumors

Read More

China IND approval for Apollomics' multikinase inhibitor APL-102

Read More

Sorrento files IND for phase I study of intranasal COVI-DROPS

Read More

New phase I study evaluates EDG-5506 for Becker muscular dystrophy

Read More